HBM Healthcare Investments (HBMN)

Business description

HBM Healthcare Investments (previously HBM BioVentures, renamed in 2012) aims to generate long-term gains through investment in private and public companies in the human medicine, biotech, medtech and diagnostics sectors, and related areas. It invests worldwide, predominantly in private companies, either directly or through funds, and many of its publicly listed holdings began as private equity investments.

Stock data

Market cap.€855.6m
Last close€117.20
High / Low (52 weeks)€117.2 / €93.0
Stock market listingSW
Forecast net debt (m)N/A
Forecast gearing ratio (%)N/A
TeamInvestment Companies
SectorInvestment Companies

Other companies in sector Show

Aberdeen New Dawn Investment Trust Aberdeen New Thai Investment Trust
Aberdeen Private Equity Fund Aberdeen UK Tracker Trust
AcenciA Debt Strategies Acorn Income Fund
Alliance Trust Altamir SCA
Amphion Innovations APQ Global
Aurelius Bailador Tech Investments
Bankers Investment Trust (The) BB Biotech
Biotech Growth Trust (The) BlackRock Greater Europe Investment Trust
BlackRock Hedge Selector BlackRock Latin American Inv. Trust
British Portfolio Trust Brunner Investment Trust (The)
Canadian General Investments Carador Income Fund
Charles Stanley Circle Property
City Natural Resources Conversus Capital
CQS Rig Finance Fund CVC Credit Partners
Detour Gold Deutsche Beteiligungs
Dexion Commodities Diverse Income Trust (The)
DouglasBay Capital Dunedin Enterprise Investment Trust
DW Catalyst Fund Edinburgh Worldwide Investment Trust (The)
European Assets Trust European Investment Trust Plc (The)
F&C Managed Portfolio Growth F&C Managed Portfolio Income
F&C US Smaller Companies Fidelity China Special Situations
Fidelity European Values Finsbury Growth & Income Trust
Foreign & Colonial Investment Trust Gartmore Growth Opportunities
Gartmore Irish Growth Fund Geiger Counter Limited
GLI Alternative Finance Global Resources Investment Trust
Golden Prospect Precious Metals Hansa Trust
HarbourVest Global Private Equity HarbourVest Senior Loans Europe
Heliad Equity Partners Henderson Alternative Strategies Trust
Henderson Far East Income Limited Henderson Global Trust
Henderson Global Trust Henderson International Income Trust
HSBC Infrastructure Company Infrastructure India
International Biotechnology Trust Invesco Asia Trust
Invesco Income Growth Trust Is Private Equity
JP Morgan Private Equity Limited JPMorgan Brazil Investment Trust
JPMorgan European Smaller Companies Trust JPMorgan Global Convertibles Income Fund
JPMorgan Global Growth & Income JPMorgan Indian Investment Trust
Jupiter Green Investment Trust Jupiter UK Growth Investment Trust
Jupiter US Smaller Companies JZ Capital Partners Limited
Lazard World Trust Fund Leaf Clean Energy Company
LMS Capital Lowland Investment Company PLC
LPEQ Martin Currie Asia Unconstrained Trust
Martin Currie Global Portfolio Trust Middlefield Canadian Income
Miton Global Opportunities Miton Income Opportunities Trust
New City Energy Ocean Wilsons Holdings
Pacific Assets Trust Phaunos Timber Fund
Polar Capital Global Healthcare Growth and Income Trust PXP Vietnam Fund
Qatar Investment Fund Rathbone Brothers
RENN Universal Growth Investment Trust Schroder AsiaPacific Fund
Schroder Global Real Estate Securities Scottish Oriental Smaller Companies Trust
Securities Trust of Scotland Seneca Global Income & Growth Trust
Sigma Capital Group Standard Life Equity Income Trust
Standard Life Investments Property Income Trust Standard Life Pvt. Equity Trust
Standard Life UK Smaller Companies Trust Strategic Equity Capital
Taiwan Fund (The) Templeton Emerging Markets Investment Trust
Tetragon Financial Group The Law Debenture Corporation
The Merchants Trust The North American Income Trust
The Scottish Investment Trust Tiso Blackstar Group
TR European Growth trust UK Commercial Property Trust
Utilico Emerging Markets Vietnam Holding Asset Management
Vietnam Infrastructure Fund VinaCapital Vietnam Opportunity Fund
VinaLand Vision Opportunity China Fund
WAM Active WAM Capital
WAM Research Witan Investment Trust
Witan Pacific Investment Trust Worldwide Healthcare Trust
YFM Equity Partners

Investment summary

HBM Healthcare Investments (HBMN) is a Switzerland-listed closed-end fund investing in listed and private healthcare companies globally. In a volatile stock market environment, the fund has performed strongly in NAV total return terms, rising to the top of its peer group over one and three years. Factors behind the positive performance include strong exits/IPO values from private companies, premium takeovers of listed stocks, good clinical newsflow from some holdings and the lower volatility of private investments. The managers point to approaching clinical catalysts for a number of the top holdings, where early data suggests newsflow may be positive, leading to substantial (although by no means guaranteed) upside potential. The shares currently yield 5.5%.

Last updated on 21/11/2016

Key management

Andreas Wicki, CEO
Erwin Troxler, CFO

Company address

Bundesplatz 1
P.O. Box 1145
Zug
CH-6301
Switzerland
View website